Drug Discovery Services Market Regional Share
The rise of biologics is fueling the growth of the "Drug Discovery Services Market". Unlike small-molecule drugs, biologics require advanced capabilities in protein engineering, cell-based assays, and biomarker analysis.
Service providers with expertise in biologics can deliver high-value research, especially in oncology, autoimmune disorders, and rare diseases. These therapies often have better specificity and fewer side effects, making them increasingly popular among healthcare providers.
While biologics offer tremendous opportunities, their development is more complex and costly. This creates a greater need for specialized outsourcing partners who can manage both the scientific and regulatory complexities of biologic drug discovery.
1 View